With more than 100 non-inferiority or equivalence trials published per year in many areas of research (Piaggio et al., 2012), statistical and methodological issues involved in these trials become increasingly important. A recent article by Rief and Hofmann (2018) suggests, however, that some of these issues are not sufficiently clear. For this reason, central issues will be discussed here and some misunderstandings will be addressed
When designing a noninferiority/equivalence trial, the sponsor intends to show efficacy by demonstra...
Background The classification of phase 3 trials as superiority or non-inferiority has become routine...
Psychologists must be able to test both for the presence of an effect and for the absence of an effe...
With more than 100 non-inferiority or equivalence trials published per year in many areas of researc...
With improvements in care over time it becomes harder to improve clinical outcomes in those conditio...
\u3cp\u3eScientists should be able to provide support for the absence of a meaningful effect. Curren...
One of the most important critical decision to be taken when designing a randomized controlled trial...
BACKGROUND: The interpretation of the results of active-control trials regarding the efficacy and sa...
International audienceNon-inferiority and equivalence trials aim to promote new treatments that are ...
Abstract Background The interpretation of the results of active-control trials regarding the efficac...
AbstractFor the purpose of comparing the efficacy and safety of a Similar Biotherapeutic Product (SB...
This paper provides a brief overview and also critiques some of the issues related to the concepts o...
In behavioral science research there is often the need to determine if an outcome variable differs, ...
The field of psychology, as with many other disciplines, has been increasingly interested in being a...
Despite decades of experience with non-inferiority trials, they remain a source of great controversy...
When designing a noninferiority/equivalence trial, the sponsor intends to show efficacy by demonstra...
Background The classification of phase 3 trials as superiority or non-inferiority has become routine...
Psychologists must be able to test both for the presence of an effect and for the absence of an effe...
With more than 100 non-inferiority or equivalence trials published per year in many areas of researc...
With improvements in care over time it becomes harder to improve clinical outcomes in those conditio...
\u3cp\u3eScientists should be able to provide support for the absence of a meaningful effect. Curren...
One of the most important critical decision to be taken when designing a randomized controlled trial...
BACKGROUND: The interpretation of the results of active-control trials regarding the efficacy and sa...
International audienceNon-inferiority and equivalence trials aim to promote new treatments that are ...
Abstract Background The interpretation of the results of active-control trials regarding the efficac...
AbstractFor the purpose of comparing the efficacy and safety of a Similar Biotherapeutic Product (SB...
This paper provides a brief overview and also critiques some of the issues related to the concepts o...
In behavioral science research there is often the need to determine if an outcome variable differs, ...
The field of psychology, as with many other disciplines, has been increasingly interested in being a...
Despite decades of experience with non-inferiority trials, they remain a source of great controversy...
When designing a noninferiority/equivalence trial, the sponsor intends to show efficacy by demonstra...
Background The classification of phase 3 trials as superiority or non-inferiority has become routine...
Psychologists must be able to test both for the presence of an effect and for the absence of an effe...